Tuesday, August 13, 2024

🌎 Hormel Foods Upgraded, Dell Technologies Upgraded, Academy Sports and Outdoors Downgraded and more...

Ratings changes for Starbucks, Syros Pharmaceuticals, Syros Pharmaceuticals, Vodafone Group Public, Viant Technology, Vanda Pharmaceuticals, Odyssey Marine Exploration and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
August 13th, 2024
S and P pricesDow pricesQQQ prices
Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Subscribe on YouTube 


Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Analysts' Upgrades
  • Atea Pharmaceuticals (NASDAQ:AVIR) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $6.88 price target on the stock, up previously from $2.00. This represents a 86.4% upside from the current price of $3.69.
  • Ducommun (NYSE:DCO) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $80.00 price target on the stock, up previously from $64.00. This represents a 23.5% upside from the current price of $64.78.
  • Dell Technologies (NYSE:DELL) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating. They now have a $97.00 price target on the stock. This represents a 3.3% downside from the current price of $100.26.
  • First Industrial Realty Trust (NYSE:FR) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $64.00 price target on the stock. This represents a 18.5% upside from the current price of $54.03.
  • Hormel Foods (NYSE:HRL) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $37.00 price target on the stock, up previously from $33.00. This represents a 16.7% upside from the current price of $31.70.
  • Littelfuse (NASDAQ:LFUS) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $280.00 price target on the stock, up previously from $270.00. This represents a 13.9% upside from the current price of $245.85.
  • Alliant Energy (NASDAQ:LNT) was upgraded by analysts at LADENBURG THALM/SH SH from a "neutral" rating to a "buy" rating. They now have a $62.50 price target on the stock, up previously from $50.00. This represents a 11.4% upside from the current price of $56.09.
  • Starbucks (NASDAQ:SBUX) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $110.00 price target on the stock, up previously from $81.00. This represents a 15.9% upside from the current price of $94.91.
  • ARS Pharmaceuticals (NASDAQ:SPRY) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $22.00 price target on the stock, up previously from $18.00. This represents a 84.6% upside from the current price of $11.92.
  • View today's most recent analysts' upgrades at MarketBeat.com right arrow


Analysts' Downgrades
  • Academy Sports and Outdoors (NASDAQ:ASO) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating. They now have a $54.00 price target on the stock, down previously from $58.00. This represents a 8.0% upside from the current price of $49.98.
  • CenterPoint Energy (NYSE:CNP) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $28.00 price target on the stock, down previously from $32.00. This represents a 8.8% upside from the current price of $25.74.
  • Cytokinetics (NASDAQ:CYTK) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $60.00 price target on the stock, down previously from $85.00. This represents a 9.2% upside from the current price of $54.92.
  • Danimer Scientific (NYSE:DNMR) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating. They now have a $1.00 price target on the stock, down previously from $2.00. This represents a 157.9% upside from the current price of $0.39.
  • Maravai LifeSciences (NASDAQ:MRVI) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $10.00 price target on the stock, down previously from $11.00. This represents a 15.9% upside from the current price of $8.63.
  • Pacira BioSciences (NASDAQ:PCRX) was downgraded by analysts at Truist Financial Co. from a "buy" rating to a "sell" rating. They now have a $8.00 price target on the stock, down previously from $30.00. This represents a 33.0% downside from the current price of $11.94.
  • Triumph Group (NYSE:TGI) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $15.00 price target on the stock, down previously from $19.00. This represents a 16.6% upside from the current price of $12.86.
  • Warner Bros. Discovery (NASDAQ:WBD) was downgraded by analysts at Sanford C. Bernstein from an "outperform" rating to a "market perform" rating. They now have a $8.00 price target on the stock, down previously from $10.00. This represents a 17.0% upside from the current price of $6.84.
  • ZoomInfo Technologies (NASDAQ:ZI) was downgraded by analysts at Daiwa Capital Markets from an "outperform" rating to a "neutral" rating. They now have a $9.00 price target on the stock, down previously from $15.00. This represents a 1.8% upside from the current price of $8.84.
  • View today's most recent analysts' downgrades at MarketBeat.com right arrow


Analysts' New Coverage
  • Artiva Biotherapeutics (NASDAQ:ARTV) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $23.00 price target on the stock. This represents a 105.9% upside from the current price of $11.17.
  • Artiva Biotherapeutics (NASDAQ:ARTV) is now covered by analysts at Wedbush. They set an "outperform" rating and a $18.00 price target on the stock. This represents a 61.1% upside from the current price of $11.17.
  • Artiva Biotherapeutics (NASDAQ:ARTV) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.The current price is $11.17.
  • Artiva Biotherapeutics (NASDAQ:ARTV) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $23.00 price target on the stock. This represents a 105.9% upside from the current price of $11.17.
  • Artiva Biotherapeutics (NASDAQ:ARTV) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $21.00 price target on the stock. This represents a 88.0% upside from the current price of $11.17.
  • iTeos Therapeutics (NASDAQ:ITOS) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $31.00 price target on the stock. This represents a 103.3% upside from the current price of $15.25.
  • New York Mortgage Trust (NASDAQ:NYMT) is now covered by analysts at Janney Montgomery Scott. They set a "neutral" rating and a $7.00 price target on the stock. This represents a 12.9% upside from the current price of $6.20.
  • Southern Missouri Bancorp (NASDAQ:SMBC) is now covered by analysts at Stephens. They set an "overweight" rating and a $60.00 price target on the stock. This represents a 19.5% upside from the current price of $50.19.
  • Sable Offshore (NYSE:SOC) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $19.00 price target on the stock. This represents a 33.2% upside from the current price of $14.26.
  • Veralto (NYSE:VLTO) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $118.00 price target on the stock. This represents a 10.6% upside from the current price of $106.67.
  • Xylem (NYSE:XYL) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $165.00 price target on the stock. This represents a 28.0% upside from the current price of $128.91.
  • Zapata Computing (NASDAQ:ZPTA) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $1.75 price target on the stock. This represents a 185.5% upside from the current price of $0.61.
  • View today's most recent analysts' new coverage at MarketBeat.com right arrow

Upgrade Your Subscription
Manage Your Watchlist
Join Our Facebook Group

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
 
© 2006-2024 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: Man who Predicted Trump 2016 Win: "Prepare for Election Meltdown"

No comments:

Post a Comment

Gold Is SOARING -- Here's What You Need to Do

Everything is lining up perfectly for a historic gold bull run. One gold expert says he's found the best...